Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 16, 2026
TickeronGET DAILY SIGNALS
Onto Innovation (ONTO): A Closer Look at Its Place in Semiconductor Process Control

Onto Innovation (ONTO): A Closer Look at Its Place in Semiconductor Process Control

Key Takeaways

  • ONTO represents Onto Innovation Inc., a U.S. supplier of process control equipment and software for the semiconductor sector.
  • The firm emerged in October 2019 from the merger of Nanometrics Incorporated, founded in 1975, and Rudolph Technologies, with origins dating back to 1940.
  • Its focus lies in metrology, defect inspection, advanced-packaging lithography, and factory analytics software aimed at boosting chip manufacturing yields.
  • Main competitors include larger players like KLA Corporation along with specialists such as Nova and Camtek.
  • Headquartered in Wilmington, Massachusetts, the company serves semiconductor makers, wafer suppliers, and advanced-packaging firms globally.

Getting Started with Onto Innovation

Onto Innovation Inc. develops and supplies process control tools essential to semiconductor manufacturing. Listed on the New York Stock Exchange as ONTO, the company operates in metrology, defect inspection, and advanced packaging. These tools help chipmakers measure and monitor production to enhance quality and cut waste. From what I see, investors track ONTO because it provides the precise equipment required as devices shrink in size and advanced packaging grows more complex, especially with demand tied to artificial intelligence chips.

Company Background and Operations

Onto Innovation resulted from a merger of equals between Nanometrics Incorporated and Rudolph Technologies, Inc., completed in October 2019. Nanometrics began in 1975 with a focus on optical metrology, while Rudolph’s roots extend to 1940. The combination created a broader specialist in measurement, inspection, and lithography. The company is based in Wilmington, Massachusetts, and maintains operations across the U.S. and key regions including Taiwan, South Korea, Japan, China, Singapore, and Europe. Michael P. Plisinski has been chief executive officer since before the merger.

Revenue comes mainly from capital equipment sales, supported by recurring income from parts, service, and software. Product categories include metrology systems for critical dimensions and film thickness, defect inspection tools for wafers and packages, advanced-packaging lithography systems, and analytics software for yield management. These solutions also serve markets such as LEDs, power devices, CMOS image sensors, RF filters, and MEMS. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Position in the Market and Key Competitors

Onto Innovation stands as a focused supplier in semiconductor process control. Its main rival is KLA Corporation (KLAC), with additional competition from Nova Ltd. (NVMI) and Camtek Ltd. (CAMT). The company sets itself apart through its range across the value chain, strength in advanced packaging, and combined metrology, inspection, and lithography offerings. Platforms like Dragonfly and JetStep support growth in the advanced-packaging segment.

Why This Stock Draws Investor Attention

Investors follow ONTO due to its alignment with structural trends in chip manufacturing. Shrinking node sizes demand more precise metrology to sustain yields, while advanced packaging methods such as hybrid bonding and high-bandwidth memory for AI applications create fresh needs for inspection and lithography. A diversified customer base and exposure to both front-end and back-end processes provide balanced positioning within the sector.

Key Risks to Consider

Semiconductor equipment companies like Onto Innovation face cyclical capital spending tied to macroeconomic conditions, geopolitics, and demand shifts. Competition from larger rivals such as KLA remains intense, and customer concentration can influence results. Trade restrictions and export controls add exposure, particularly with significant operations in Asia. Ongoing research and development investment is essential to match rapid advances in chip technology.

Exploring Broader Trends with AI Tools

In my view, tools like Tickeron’s AI Trend Prediction Engine can help put these industry dynamics into context by highlighting patterns across related stocks. One thing that stands out is how such platforms support a more structured review of sector opportunities without replacing individual analysis.

Wrapping Up the Picture

Onto Innovation holds a distinct position as a provider of process control, inspection, and advanced-packaging lithography equipment. The 2019 merger expanded its portfolio and reach, while exposure to trends like advanced packaging and precise manufacturing keeps it relevant. As with peers in the space, performance links closely to industry capital spending cycles, so context within global chip production remains important.

AI Screener

I’ve found Tickeron’s AI Screener useful for quickly scanning semiconductor-related names and comparing fundamentals or signals across the group. It lets me apply filters for trends and patterns to refine ideas that fit my overall approach, which helps keep research efficient when evaluating companies like ONTO.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ONTO

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


ONTO's RSI Indicator ascending out of oversold territory

The RSI Oscillator for ONTO moved out of oversold territory on November 06, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 22 similar instances when the indicator left oversold territory. In 20 of the 22 cases the stock moved higher. This puts the odds of a move higher at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 13, 2026. You may want to consider a long position or call options on ONTO as a result. In 79 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 82%.

The Moving Average Convergence Divergence (MACD) for ONTO just turned positive on November 10, 2026. Looking at past instances where ONTO's MACD turned positive, the stock continued to rise in 37 of 43 cases over the following month. The odds of a continued upward trend are 86%.

Following a +10.83% 3-day Advance, the price is estimated to grow further. Considering data from situations where ONTO advanced for three days, in 265 of 326 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

ONTO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

ONTO moved below its 50-day moving average on October 12, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ONTO crossed bearishly below the 50-day moving average on October 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 67%.

The 50-day moving average for ONTO moved below the 200-day moving average on November 04, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ONTO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

The Aroon Indicator for ONTO entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 61 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. ONTO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.423) is normal, around the industry mean (5.670). P/E Ratio (64.899) is within average values for comparable stocks, (68.795). Projected Growth (PEG Ratio) (0.817) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (10.787) is also within normal values, averaging (27.897).

The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

Notable companies

The most notable companies in this group are Applied Materials (NASDAQ:AMAT), Lam Research Corp (NASDAQ:LRCX), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 46.26B. The market cap for tickers in the group ranges from 310.74K to 665.22B. ASMLF holds the highest valuation in this group at 665.22B. The lowest valued company is SMTK at 310.74K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was 6%. For the same Industry, the average monthly price growth was -16%, and the average quarterly price growth was -35%. ONTO experienced the highest price growth at 18%, while SMTK experienced the biggest fall at -32%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was -32%. For the same stocks of the Industry, the average monthly volume growth was -12% and the average quarterly volume growth was -52%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 62
P/E Growth Rating: 44
Price Growth Rating: 63
SMR Rating: 71
Profit Risk Rating: 76
Seasonality Score: 28 (-100 ... +100)
AI Patterns 1
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a company, which engages in developing process control systems and offers process control, combining global scale with an expanded portfolio of technologies

Industry ElectronicProductionEquipment

Industry
N/A
Address
16 Jonspin Road
Phone
+1 978 253-6200
Employees
1615
Web
https://www.ontoinnovation.com
Interact to see
Advertisement
The central price target used here is $400 , roughly 35% above Alphabet's latest verified closing price of $295.77 (November 13, 2026). This target is the arithmetic mean of verified analyst price targets reviewed, not a single analyst's forecast; independent data providers report comparable consensus averages in the high-$390s to low-$400s.
Upcoming catalysts: Integration of advertising into AI Overviews and Gemini conversations, the scaling of Gemini 3 and newer models across Search and Cloud, and the commercial ramp of the $32 billion Wiz cloud-security acquisition could all shape sentiment into 2026. Strategic positioning: Alphabet's vertically integrated artificial intelligence (AI) stack — from custom TPU (Tensor Processing Unit) chips to the Gemini models to Google Cloud — supports a durable, cost-advantaged position in the AI build-out.
The TETH exchange-traded fund (ETF) is the 21Shares Ethereum Staking ETF, a spot Ethereum fund listed on Cboe BZX, and it does not carry conventional analyst price targets. The $14 objective used here is a technical milestone discussed in public market commentary — roughly the zone where Ethereum could begin confirming a recovery — not an analyst consensus.
The central target of $6.70 is the arithmetic mean of seven recent, individually verified analyst price targets, rounded from $6.67. At a latest price near $3.70, reaching $6.70 would require roughly 81% upside — a very large move.
Lead catalyst: Chemomab has secured alignment with the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) on a single Phase 3 registration trial for nebokitug in primary sclerosing cholangitis (PSC), a rare liver disease with no approved disease-modifying therapy. Strategic pivot: A planned merger with Scipher Medicine is expected to close by year-end 2026, extending nebokitug into an AI-powered, precision-medicine Phase 2 trial in rheumatoid arthritis (RA).